{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T09:59:07Z","timestamp":1782295147018,"version":"3.54.5"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Frequently, the community pharmacies are the only points of consultation for upper-gastrointestinal symptomology. However, the heterogeneity of symptoms often limits the correct management of the patient. The study aim is to describe the epidemiological and clinical characteristics of patients with upper-gastrointestinal symptoms who ask for advice in community pharmacies.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A cross-sectional study was performed in 134 Spanish pharmacies (June-October 2022) and we included 1,360 patients. We collected sociodemographic, clinical variables and current medication data. The pharmacist evaluated the gastrointestinal symptoms through the application of the GERD Impact Scale (GIS questionnaire). Patients were classified into three groups according to their symptoms: epigastric, retrosternal and overlapping symptoms.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Median age was 49\u00a0years (interquartile range 36\u201362\u00a0years) and 59.3% were women. Most patients reported overlapping symptoms (738%, 54.3%), 433 (31.8%) retrosternal and 189 (13.9%) epigastric symptoms. Patients with overlapping symptoms were more likely to associated consumption of foods and\/or drinks and symptoms and showed lower scores on the GIS scale (median 26, IQR 20-30) than those with epigastric (median 32, IQR 29-33) and retrosternal (median 32, IQR 28-34) symptoms (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). Patients in treatment with a combination of alginates and antiacids were more likely to think that it better alleviated their symptoms in all the patients included (<jats:italic>p<\/jats:italic> = 0.012).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> More than half of the patients showed overlapping symptoms and were more likely to associate their symptoms with dietary habits and having poorer scores in the GIS scale. Clinical awareness of such overlapping condition would help optimize the management of patients with upper gastrointestinal symptoms in practice.<\/jats:p>","DOI":"10.3389\/fphar.2023.1162370","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T04:32:50Z","timestamp":1686630770000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence and risk factors of upper gastrointestinal symptoms in community pharmacies in Spain: a cross-sectional study"],"prefix":"10.3389","volume":"14","author":[{"given":"Mar\u00eda","family":"Puig-Molt\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Lumbreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"L\u00f3pez-Pintor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"B2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s11096-015-0150-z","article-title":"The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors","volume":"37","author":"Boardman","year":"2015","journal-title":"Int. J. Clin. Pharm."},{"key":"B3","volume-title":"BOE-A-2006-13554 Ley 29\/2006, de 26 de julio, de garant\u00edas y uso racional de los medicamentos y productos sanitarios","year":"2006"},{"key":"B4","volume-title":"BOE-A-2015-8343 Real Decreto Legislativo 1\/2015, de 24 de julio, por el que se aprueba el texto refundido de la Ley de garant\u00edas y uso racional de los medicamentos y productos sanitarios","year":"2015"},{"key":"B5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-2982.2011.01845.x","article-title":"Overlap of dyspepsia and gastroesophageal reflux in the general population: One disease or distinct entities?","volume":"24","author":"Choung","year":"2012","journal-title":"Neurogastroenterol. Motil. Official J. Eur. Gastrointest. Motil. Soc."},{"key":"B6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.20524\/aog.2018.0314","article-title":"Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: Common overlapping gastrointestinal disorders","volume":"31","author":"de Bortoli","year":"2018","journal-title":"Ann. Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","article-title":"Rome IV\u2014functional GI disorders: Disorders of gut-brain interaction","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cgh.2017.07.041","article-title":"Prevalence of dyspepsia in individuals with gastroesophageal reflux-type symptoms in the community: A systematic review and meta-analysis","volume":"16","author":"Eusebi","year":"","journal-title":"Clin. Gastroenterology Hepatology Official Clin. Pract. J. Am. Gastroenterological Assoc."},{"key":"B9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1136\/gutjnl-2016-313589","article-title":"Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: A meta-analysis","volume":"67","author":"Eusebi","year":"","journal-title":"Gut"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3748\/wjg.15.1690","article-title":"Body weight, lifestyle, dietary habits and gastroesophageal reflux disease","volume":"15","author":"Festi","year":"2009","journal-title":"World J. Gastroenterology WJG"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1136\/gutjnl-2014-307843","article-title":"Global prevalence of, and risk factors for, uninvestigated dyspepsia: A meta-analysis","volume":"64","author":"Ford","year":"2015","journal-title":"Gut"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.14309\/ajg.0000000000000619","article-title":"Gastroesophageal reflux disease\u2014functional dyspepsia overlap: Do birds of a feather flock together?","volume":"115","author":"Geeraerts","year":"2020","journal-title":"Official J. Am. Coll. Gastroenterology | ACG"},{"key":"B13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cgh.2008.11.021","article-title":"A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease","volume":"7","author":"Gerson","year":"2009","journal-title":"Clin. Gastroenterology Hepatology Official Clin. Pract. J. Am. Gastroenterological Assoc."},{"key":"B14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5056\/jnm.2011.17.3.235","article-title":"Epidemiology of uninvestigated and functional dyspepsia in asia: Facts and fiction","volume":"17","author":"Ghoshal","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"key":"B15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/s0399-8320(05)80756-0","article-title":"Prevalence of functional gastrointestinal disorders in a population of subjects consulting for gastroesophageal reflux disease in general practice","volume":"29","author":"Guillemot","year":"2005","journal-title":"Gastroenterologie Clinique Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000235953","article-title":"Management of reflux symptoms with over-the-counter proton pump inhibitors: Issues and proposed guidelines","volume":"80","author":"Haag","year":"2009","journal-title":"Digestion"},{"key":"B17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3746\/pnf.2021.26.4.367","article-title":"Dietary intake in relation to the risk of reflux disease: A systematic review","volume":"26","author":"Heidarzadeh-Esfahani","year":"2021","journal-title":"Prev. Nutr. Food Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s11096-011-9489-y","article-title":"Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD","volume":"33","author":"Holtmann","year":"2011","journal-title":"Int. J. Clin. Pharm."},{"key":"B19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s40265-017-0712-6","article-title":"The safety of appropriate use of over-the-counter proton pump inhibitors: An evidence-based review and Delphi consensus","volume":"77","author":"Johnson","year":"2017","journal-title":"Drugs"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.1440-1746.2010.06249.x","article-title":"Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life","volume":"25","author":"Kaji","year":"2010","journal-title":"J. Gastroenterology Hepatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1001\/archinte.166.9.965","article-title":"Are lifestyle measures effective in patients with gastroesophageal reflux disease?: An evidence-based approach","volume":"166","author":"Kaltenbach","year":"2006","journal-title":"Archives Intern. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.5009\/gnl.2014.8.2.160","article-title":"The risk factors and quality of life in patients with overlapping functional dyspepsia or peptic ulcer disease with gastroesophageal reflux disease","volume":"8","author":"Lee","year":"2014","journal-title":"Gut Liver"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dote.12535","article-title":"Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: A systematic review and meta-analysis","volume":"30","author":"Leiman","year":"2017","journal-title":"Dis. Esophagus Official J. Int. Soc. Dis. Esophagus"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/s0016-5085(97)70025-8","article-title":"Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in olmsted county, Minnesota","volume":"112","author":"Locke","year":"1997","journal-title":"Gastroenterology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"9807","DOI":"10.3390\/ijerph19169807","article-title":"EsReflux protocol: Epidemiological study of heartburn and reflux-like symptoms in Spanish community pharmacies","volume":"19","author":"L\u00f3pez-Pintor","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00535-015-1073-0","article-title":"Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: A multicenter prospective observational study","volume":"50","author":"Matsuhashi","year":"2015","journal-title":"J. Gastroenterology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1055\/a-0736-5959","article-title":"Alginate on demand as add-on for patients with gastro-oesophageal reflux disease and insufficient PPI effect","volume":"144","author":"M\u00fcller","year":"2019","journal-title":"Dtsch. Med. Wochenschr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.gastrohep.2008.12.004","article-title":"Validation of the reflux disease questionnaire (RDQ) and gastrointestinal impact scale (GIS) in patients with gastroesophageal reflux disease in the Spanish population","volume":"32","author":"Nuevo","year":"2009","journal-title":"Gastroenterol. Y Hepatol."},{"key":"B29","volume-title":"Statista","year":"2022"},{"key":"B30","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/nmo.12305","article-title":"The gastric accommodation response to meal intake determines the occurrence of transient lower esophageal sphincter relaxations and reflux events in patients with gastro-esophageal reflux disease","volume":"26","author":"Pauwels","year":"2014","journal-title":"Neurogastroenterol. Motil."},{"key":"B31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1365-2982.2009.01262.x","article-title":"Dyspeptic symptoms in the general population: A factor and cluster analysis of symptom groupings","volume":"21","author":"Piessevaux","year":"2009","journal-title":"Neurogastroenterol. Motil. Official J. Eur. Gastrointest. Motil. Soc."},{"key":"B32","doi-asserted-by":"publisher","first-page":"CD011194","DOI":"10.1002\/14651858.CD011194.pub3","article-title":"Proton pump inhibitors for functional dyspepsia","volume":"11","author":"Pinto-Sanchez","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1365-2036.2006.02733.x","article-title":"Prevalence of gastro-oesophageal reflux disease in Spain and associated factors","volume":"23","author":"Ponce","year":"2006","journal-title":"Alimentary Pharmacol. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrgastro.2012.253","article-title":"Overlap of functional dyspepsia and GERD\u2014Diagnostic and treatment implications","volume":"10","author":"Quigley","year":"2013","journal-title":"Nat. Rev. Gastroenterology Hepatology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1111\/j.1365-2036.2006.02952.x","article-title":"Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study","volume":"23","author":"Ronkainen","year":"2006","journal-title":"Alimentary Pharmacol. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/apt.15308","article-title":"Duodenal eosinophilia is associated with functional dyspepsia and new onset gastro-oesophageal reflux disease","volume":"50","author":"Ronkainen","year":"2019","journal-title":"Alimentary Pharmacol. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1053\/j.gastro.2007.09.039","article-title":"Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease","volume":"133","author":"Schey","year":"2007","journal-title":"Gastroenterology"},{"key":"B38","volume-title":"Update on the management of patients with heartburn and\/or reflux in primary care and community pharmacy pharmacy [Spanish]. 1","year":"2019"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1136\/gut.2004.053355","article-title":"Prevalence of acid reflux in functional dyspepsia and its association with symptom profile","volume":"54","author":"Tack","year":"2005","journal-title":"Gut"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","article-title":"Functional gastroduodenal disorders","volume":"130","author":"Tack","year":"2006","journal-title":"Gastroenterology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1365-2036.2007.03565.x","article-title":"New algorithm for the treatment of gastro-oesophageal reflux disease","volume":"27","author":"Tytgat","year":"2008","journal-title":"Alimentary Pharmacol. Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"11845","DOI":"10.26355\/eurrev_202011_23841","article-title":"Efficacy and safety of alginate formulations in patients with gastroesophageal reflux disease: A systematic review and meta-analysis of randomized controlled trials","volume":"24","author":"Zhao","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1162370\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T04:32:57Z","timestamp":1686630777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1162370\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":41,"alternative-id":["10.3389\/fphar.2023.1162370"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1162370","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"article-number":"1162370"}}